| Biotechnology feed | All feeds
13 /PRNewswire-FirstCall/ -- Micromet, Inc.
(NASDAQ: MITI) , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that... PR Newswire: Nov 13 2008 2:34PM Matching: leukemia lymphoma t cell acute Find similar documents
(Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that... Business Journal of Milwaukee: Nov 13 2008 12:36PM Matching: leukemia lymphoma t cell acute Find similar documents
(Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that... The Business Journal Phoenix: Nov 13 2008 12:32PM Matching: leukemia lymphoma t cell acute Find similar documents
(Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that... Cincinnati Business Journal: Nov 13 2008 12:31PM Matching: leukemia lymphoma t cell acute Find similar documents
(Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that... San Francisco Business Times: Nov 13 2008 12:26PM Matching: leukemia lymphoma t cell acute Find similar documents
(Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that two studies on its T cell engaging BiTE... TradingMarkets: Nov 13 2008 12:38PM Matching: leukemia lymphoma t cell acute Find similar documents
(New Haven, CT), Yale University (New Haven, CT) Appl.
No.: 11/064,533 Filed:... PharmCast: Nov 12 2008 1:04PM Matching: leukemia lymphoma t cell acute Find similar documents
The 2008 Nobel Prize for Medicine went to three virus hunters, one who discovered the human papilloma virus (HPV), the cause of many... Pharmaceutical Executive: Oct 7 2008 5:19AM Matching: leukemia lymphoma t cell htlv Find similar documents
In return, UAF Technologies and Research (UTR) will receive a cash assignment fee, cash payments on the achievement of certain defined milestones... Pharmaceutical Business Review: Sep 25 2008 7:34AM Matching: leukemia t cell htlv Find similar documents
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright 1997-2008 - BioPortfolio Limited.
